ISUL:NASDAQGraniteShares 2x Long ISRG Daily ETF Analysis
Data as of 2026-04-11 - not real-time
$22.76
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The fund is trading at $22.76, well below its 20‑day ($24.60), 50‑day ($26.65) and 200‑day ($31.74) simple moving averages, underscoring a pronounced bearish bias. RSI at 34.5 suggests the price is approaching oversold territory, yet the 30‑day volatility of 44.3% indicates price swings remain extreme. The MACD histogram is marginally positive, offering a faint bullish signal, but the overall trend direction is listed as bearish and the fund has suffered a YTD decline of ‑36.1%. With a leveraged 2× exposure to Intuitive Surgical (ISRG), the ETF’s beta of 1.98 amplifies market moves, and the maximum drawdown of ‑44.7% reflects the downside risk inherent in such structures. Liquidity is constrained: average daily volume hovers around 10‑14k shares and total assets are only $2.9 M, raising concerns about execution at larger sizes. The expense ratio of 1.5% further erodes returns, especially in a flat or declining market environment.
Given the extreme “Greed” reading on the Fear & Greed Index, market participants may be over‑optimistic, but the fund’s structural decay risk, high beta, and thin liquidity outweigh any short‑term rally potential. Investors should be wary of the daily reset mechanism, which can lead to performance divergence from the underlying stock over multi‑day horizons. The lack of a discount/premium and zero tracking error are nominal benefits that do not compensate for the leveraged decay and concentration risk. In summary, the quantitative signals point to continued pressure, high volatility, and limited upside, suggesting a cautious stance toward ISUL.
Given the extreme “Greed” reading on the Fear & Greed Index, market participants may be over‑optimistic, but the fund’s structural decay risk, high beta, and thin liquidity outweigh any short‑term rally potential. Investors should be wary of the daily reset mechanism, which can lead to performance divergence from the underlying stock over multi‑day horizons. The lack of a discount/premium and zero tracking error are nominal benefits that do not compensate for the leveraged decay and concentration risk. In summary, the quantitative signals point to continued pressure, high volatility, and limited upside, suggesting a cautious stance toward ISUL.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- price below all major moving averages
- YTD return of -36.1% and high volatility
- high beta and leveraged exposure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential rebound if ISRG fundamentals improve
- ongoing elevated volatility
- risk of leveraged decay over multi‑day periods
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- persistent high expense ratio
- structural decay and daily reset risk
- limited liquidity and concentration in a single stock
Key Metrics & Analysis
Fund Metrics
Expense Ratio1.50%
AUM$2.9M
Inception Date2025-10-06
Avg Daily Volume6,760
Premium/Discount0.00%
Tracking Error0.00%
Technical Analysis
TrendBearish
RSI34.5
Support$22.69
Resistance$27.15
MA 20$24.60
MA 50$26.65
MA 200$31.74
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09
Risk Assessment
Beta1.98
Volatility44.33%
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.